Alaunos Therapeutics, Inc. (TCRT) Form 8-K — Oct 9, 2026

$TCRTForm 8-KItems 3.01Filed Oct 9, 2026, 4:30 PM ET0001193125-26-419154Original filing

Alaunos Therapeutics received a Nasdaq delisting notice on October 5, 2026 after failing to maintain the required $2.5 million minimum stockholders' equity under Listing Rule 5550(b)(1). The company plans to timely request a hearing before the Nasdaq Hearings Panel, which will stay any suspension or delisting at least until the hearing and any granted extension expire.

Key figures

Minimum stockholders equity required: 2500000

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.